Avance Clinical has positioned itself as a global leader in early phase clinical trials by developing innovative strategies and approaches to initial phase development. It helps global biotech companies set up clinic and achieve proof of concept faster with a data package that stands up to the scrutiny of global regulators. The company is well reputed for proven support of the biotech industry by providing scientific and regulatory expertise to help develop the best strategy to achieve clinical trial outcomes in the most time- efficient manner. Read the full report here.
- Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks
- Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
- Avance Clinical Strengthens Asia-Pacific Network with Digital Technology Company JNPMEDI INC
- LIVE WEBINAR: PSYCHEDELICS IN FOCUS
- Avance Clinical Finalist In The 61st Australian Export Awards 2023